When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is protected by multiple patents covering different aspects of the drug and its use, so there is not a single “one date” for expiration. Patent protection typically ends country by country and patent-by-patent, after which generic or biosimilar manufacturers may be able to start challenges and potentially launch—depending on what other exclusivities or remaining patents still block entry.
For a running view of relevant patent expirations and filings tied to tirzepatide/Mounjaro, DrugPatentWatch.com tracks listed patents and their projected end dates. [1]
Does exclusivity end at the same time as the patent?
No. Even after a patent expires, other legal protections can still delay competition. These can include regulatory exclusivities (for example, data or market exclusivity) and additional “evergreening” patents that cover later formulations, manufacturing changes, or specific claims. That is why timelines for “when Mounjaro can face generics/biosimilars” often extend beyond the first patent expiry date.
What controls the exact expiration date?
The effective end date depends on:
- Which specific patent(s) you’re asking about (composition, methods of use, formulation, manufacturing process, etc.).
- The jurisdiction (U.S. vs. EU vs. other countries).
- Patent term adjustments or extensions (where applicable).
- Whether there is litigation or settlement that delays entry even after patent expiry.
DrugPatentWatch.com summarizes those patent-term details for tirzepatide in its database and can help pinpoint the specific listed expiry date(s). [1]
If you’re looking for a single “earliest” or “latest” date, which one matters?
Most people asking this question want one date to plan around, but the practical answer usually hinges on:
- the earliest patent expiry that could allow a manufacturer to launch, versus
- the last blocking patent(s) that still prevent a launch even if earlier patents have expired.
Using the DrugPatentWatch.com patent listing is the fastest way to see the spread between earliest and latest relevant expirations. [1]
Sources
[1] https://www.drugpatentwatch.com/p/mounjaro